Kaleo Logo
What We Do

Our Commitment

At Kaléo, the patient always comes first. We believe that patients deserve fair access to the latest innovative healthcare solutions with patient-centered designs that offer the reliability and flexibility that our patients need to live fuller, bolder lives.

Accent Lines


We are dedicated to creating solutions for life.

Parents

Patient Assistance Program

Patients facing financial hardships and who do not have insurance coverage for prescription medicines may be eligible for the Kaléo Patient Assistance Program.†

Eligible participants must have a prescription, be a legal U.S. resident, have no government or commercial drug coverage, and have an annual household income of less than $100,000.

To learn more, call (502) 213-7601

† Patients who are eligible for Medicaid coverage may be eligible for assistance to epinephrine injection, USP at no cost.

The patient is considered in everything we do. As a company founded by patients, we will always put the patients’ needs first.

Team meeting

Product Innovation

As a company founded by patients for patients, we take our commitment to the needs of patients, their families and caregivers very seriously.  Kaléo continues to build innovative healthcare solutions to protect and empower patients and their families to live fuller, bolder lives. We are proud of more than 200 issued patents that our products have earned, but more importantly, we are driven by the impact our products have on patients and families. 

Access & Affordability

We have seen firsthand, in this current healthcare system, the very real challenges patients are facing in being able to access and afford  life-transforming medicines. Similar to our product innovation process, we built our access program to help solve for these challenges and help focus on what matters most: access and affordability to patients. 

Manufacturing & Quality

Kaléo is committed to the highest standards of product and manufacturing quality. Final manufacturing and assembly of our products is conducted in the United States on a 100% automated robotic production line with more than 100 automated quality checks on each and every product. In terms of reliability, Kaléo was the first to meet the FDA’s draft guidance standard for 99.999% device reliability. Patients and their families can be confident in our approach to design quality into our products and incorporate quality into every aspect of the manufacturing process.